A randomized controlled trial comparing the effects of sitagliptin and glimepiride on endothelial function and metabolic parameters: Sapporo athero-incretin study 1 (SAIS1)

PLoS ONE

Volumn 11, Issue 10, 2016, Pages

  Nomoto, Hiroshi ^a   Miyoshi, Hideaki ^a   Furumoto, Tomoo ^a,b   Oba, Koji ^c,d   Tsutsui, Hiroyuki ^a   Inoue, Atsushi ^e   Atsumi, Tatsuya ^a   Manda, Naoki ^f   Kurihara, Yoshio ^g   Aoki, Shin ^h   Takano, Y ^a   Koyanagawa, N ^a   Miyoshi, A ^a   Yamamoto, K ^a   Yamamoto, C ^a   Nomoto, H ^a,k   Tajima, N ^a   Kameda, H ^a   Cho, K Y ^a,j   Nakagaki, O ^a   Nagai, S ^a   Kondo, T ^a   Miyoshi, H ^a   Takashina, C ⁱ   Watanabe, T ⁱ   Ohira, H ⁱ   Endo, M ^l   Kamoshima, H ^m   Inoue, A ^m   Ono, Y ⁿ   Hagiwara, S ^f   Misawa, K ^f   Tsuchida, K ^f   Manda, N ^f   Kurihara, Y ^o   Aoki, S ^p   Perfield, James W ^q   more..

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Sapporo Medical Center   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e KYUSHU HOSPITAL   (Japan)

^f Manda Memorial Hospital   (Japan)

^g Kurihara Diabetic Care Clinic   (Japan)

^h Aoki Clinic   (Japan)

ⁱ HOKKAIDO UNIVERSITY   (Japan)

^j Department of Radiological Technology   (Japan)

^k Ogasawara Clinic Sapporo Hospital   (Japan)

^l Ohtsuka Eye Hospital   (Japan)

^m Hokkaido Social Insurance Hospital   (Japan)

ⁿ Ono Ladies Clinic   (Japan)

^o Kurihara Clinic   (Japan)

^p Dental Clinic Aoki   (Japan)

^q UNIVERSITY OF MISSOURI   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLIMEPIRIDE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SITAGLIPTIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR; ANTIDIABETIC AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; METFORMIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FLOW MEDIATED DILATION; GLYCEMIC CONTROL; HEART INDEX; HEMODYNAMIC PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; OUTPATIENT; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; BLOOD; BODY MASS; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION; ENDOTHELIUM; HEMODYNAMICS; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; BIOMARKERS; BLOOD PRESSURE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; ENDOTHELIUM; FEMALE; HEMODYNAMICS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; PROSPECTIVE STUDIES; SITAGLIPTIN PHOSPHATE; SULFONYLUREA COMPOUNDS; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84991215222     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0164255     Document Type: Article

References (50)

1. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010; 375(9733):2215-22. Epub 2010/07/09. doi: 10.1016/s0140-6736(10) 60484-9 PMID: 20609967; PubMed Central PMCID: PMC2904878.
2. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. NEJM. 1998; 339(4):229-34. Epub 1998/07/23. doi: 10.1056/nejm199807233390404 PMID: 9673301.
3. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation. 1993; 88(3):837-45. Epub 1993/09/01. doi: 10.1161/01.CIR. 88.3.837 PMID: 8353913.
4. Kimura K, Minematsu K, Kazui S, Yamaguchi T. Mortality and cause of death after hospital discharge in 10, 981 patients with ischemic stroke and transient ischemic attack. Cerebrovasc Dis. (Basel, Switzerland). 2005; 19(3):171-8. Epub 2005/01/13. doi: 10.1159/000083252 PMID: 15644630.
5. Henderson A. Endothelial dysfunction: a reversible clinical measure of atherogenic susceptibility and cardiovascular inefficiency. Int J Cardiol. 1997; 62 Suppl 1:S43-8. Epub 1998/02/17. doi: 10.1016/S0167-5273(97)00212-X PMID: 9464583.
6. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA: the journal of the American Medical Association. 2002; 287(19):2570-81. Epub 2002/05/22. doi: 10.1001/jama.287.19.2570 PMID: 12020339.
7. Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocrine reviews. 2001; 22(1):36-52. Epub 2001/02/13. doi: 10.1210/edrv.22.1.0417 PMID: 11159815.
8. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007; 115(10):1285-95. Epub 2007/03/14. doi: 10.1161/circulationaha.106. 652859 PMID: 17353456.
9. Hollenberg SM, Cinel I. Bench-to-bedside review: nitric oxide in critical illness-update 2008. Critical care (London, England). 2009; 13(4):218. Epub 2009/08/12. doi: 10.1186/cc7706 PMID: 19664175; PubMed Central PMCID: PMC2750127.
10. Henry RM, Ferreira I, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, et al. Type 2 diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolism is not; The Hoorn Study. Atherosclerosis. 2004; 174(1):49-56. Epub 2004/05/12. doi: 10.1016/j. atherosclerosis.2004.01.002 PMID: 15135250.
11. White WB, Bakris GL, Bergenstal RM, Cannon CP, Cushman WC, Fleck P, et al. EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome. American heart journal. 2011; 162(4):620-6.e1. Epub 2011/10/11. doi: 10.1016/j.ahj.2011.08.004 PMID: 21982652.
12. Udell JA, Bhatt DL, Braunwald E, Cavender MA, Mosenzon O, Steg PG, et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial. Diabetes care. 2015; 38(4):696-705. Epub 2015/01/02. doi: 10. 2337/dc14-1850 PMID: 25552421.
13. Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, et al. Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. The New England journal of medicine. 2015; 373(3):232-42. Epub 2015/06/09. doi: 10.1056/NEJMoa1501352 PMID: 26052984.
14. van Poppel PC, Netea MG, Smits P, Tack CJ. Vildagliptin improves endothelium-dependent vasodilatation in type 2 diabetes. Diabetes care. 2011; 34(9):2072-7. Epub 2011/07/27. doi: 10.2337/dc10-2421 PMID: 21788633; PubMed Central PMCID: PMCPmc3161271.
15. Kubota Y, Miyamoto M, Takagi G, Ikeda T, Kirinoki-Ichikawa S, Tanaka K, et al. The dipeptidyl peptidase-4 inhibitor sitagliptin improves vascular endothelial function in type 2 diabetes. Journal of Korean medical science. 2012; 27(11):1364-70. Epub 2012/11/21. doi: 10.3346/jkms.2012.27.11.1364 PMID: 23166419; PubMed Central PMCID: PMCPmc3492672.
16. Ayaori M, Iwakami N, Uto-Kondo H, Sato H, Sasaki M, Komatsu T, et al. Dipeptidyl peptidase-4 inhibitors attenuate endothelial function as evaluated by flow-mediated vasodilatation in type 2 diabetic patients. Journal of the American Heart Association. 2013; 2(1):e003277. Epub 2013/03/26. doi: 10. 1161/jaha.112.003277 PMID: 23525426; PubMed Central PMCID: PMCPmc3603233.
17. Nomoto H, Miyoshi H, Furumoto T, Oba K, Tsutsui H, Miyoshi A, et al. A Comparison of the Effects of the GLP-1 Analogue Liraglutide and Insulin Glargine on Endothelial Function and Metabolic Parameters: A Randomized, Controlled Trial Sapporo Athero-Incretin Study 2 (SAIS2). PloS one. 2015; 10(8): e0135854. Epub 2015/08/19. doi: 10.1371/journal.pone.0135854 PMID: 26284918; PubMed Central PMCID: PMCPmc4540491.
18. Papathanassiou K, Naka KK, Kazakos N, Kanioglou C, Makriyiannis D, Pappas K, et al. Pioglitazone vs glimepiride: Differential effects on vascular endothelial function in patients with type 2 diabetes. Atherosclerosis. 2009; 205(1):221-6. Epub 2009/01/13. doi: 10.1016/j.atherosclerosis.2008.11.027 PMID: 19135671.
19. Nystrom T, Gutniak MK, Zhang Q, Zhang F, Holst JJ, Ahren B, et al. Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. American journal of physiology Endocrinology and metabolism. 2004; 287(6):E1209-15. Epub 2004/09/09. doi: 10. 1152/ajpendo.00237.2004 PMID: 15353407.
20. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. Journal of the American College of Cardiology. 2002; 39(2):257-65. Epub 2002/01/15. doi: 10.1016/S0735-1097(01)01746-6 PMID: 11788217.
21. Furumoto T, Fujii S, Nishihara K, Yamada S, Komuro K, Goto K, et al. Maladaptive arterial remodeling with systemic hypertension associated with increased concentrations in blood of plasminogen activator inhibitor type-1 (PAI-1). The American journal of cardiology. 2004; 93(8):997-1001. Epub 2004/04/15. doi: 10.1016/j.amjcard.2003.12.053 PMID: 15081442.
22. Tomiyama H, Kohro T, Higashi Y, Takase B, Suzuki T, Ishizu T, et al. A multicenter study design to assess the clinical usefulness of semi-automatic measurement of flow-mediated vasodilatation of the brachial artery. International heart journal. 2012; 53(3):170-5. Epub 2012/07/14. doi: 10.1536/ihj.53. 170 PMID: 22790685.
23. Okamoto T, Sakamaki-Sunaga M, Min S, Miura T, Iwasaki T. Acute effect of brisk walking with graduated compression stockings on vascular endothelial function and oxidative stress. Clinical physiology and functional imaging. 2013; 33(6):455-62. Epub 2013/05/25. doi: 10.1111/cpf.12052 PMID: 23701492.
24. Cesarone MR, Belcaro G, Carratelli M, Cornelli U, De Sanctis MT, Incandela L, et al. A simple test to monitor oxidative stress. International angiology: a journal of the International Union of Angiology. 1999; 18(2):127-30. Epub 1999/07/29. PMID: 10424368.
25. Oeseburg H, de Boer RA, Buikema H, van der Harst P, van Gilst WH, Sillje HH. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A. Arteriosclerosis, thrombosis, and vascular biology. 2010; 30(7):1407-14. Epub 2010/05/08, doi: 10.1161/atvbaha.110.206425 PMID: 20448207.
26. Ishibashi Y, Matsui T, Takeuchi M, Yamagishi S. Sitagliptin augments protective effects of GLP-1 against advanced glycation end product receptor axis in endothelial cells. Hormone and metabolic research = Hormon-und Stoffwechselforschung = Hormones et metabolisme. 2011; 43(10):731-4. Epub 2011/09/21. doi: 10.1055/s-0031-1284383 PMID: 21932180.
27. Liu H, Hu Y, Simpson RW, Dear AE. Glucagon-like peptide-1 attenuates tumour necrosis factor-alphamediated induction of plasminogen [corrected] activator inhibitor-1 expression. The Journal of endocrinology. 2008; 196(1):57-65. Epub 2008/01/09. doi: 10.1677/joe-07-0387 PMID: 18180317.
28. Gaspari T, Liu H, Welungoda I, Hu Y, Widdop RE, Knudsen LB, et al. A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/-mouse model. Diabetes & vascular disease research: official journal of the International Society of Diabetes and Vascular Disease. 2011; 8(2):117-24. Epub 2011/05/13. doi: 10.1177/1479164111404257 PMID: 21562063.
29. Arakawa M, Mita T, Azuma K, Ebato C, Goto H, Nomiyama T, et al. Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4. Diabetes. 2010; 59(4):1030-7. Epub 2010/01/14. doi: 10.2337/db09-1694 PMID: 20068138; PubMed Central PMCID: PMCPmc2844811.
30. Ervinna N, Mita T, Yasunari E, Azuma K, Tanaka R, Fujimura S, et al. Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice. Endocrinology. 2013; 154(3):1260-70. Epub 2013/01/23. doi: 10.1210/en.2012-1855 PMID: 23337530.
31. Mita T, Katakami N, Shiraiwa T, Yoshii H, Onuma T, Kuribayashi N, et al. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial. Diabetes care. 2016; 39(3):455-64. Epub 2016/01/30. doi: 10.2337/dc15-2145 PMID: 26822324.
32. Pyke C, Heller RS, Kirk RK, Orskov C, Reedtz-Runge S, Kaastrup P, et al. GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody. Endocrinology. 2014; 155(4):1280-90. Epub 2014/01/29. doi: 10.1210/en.2013-1934 PMID: 24467746.
33. Benjamin EJ, Larson MG, Keyes MJ, Mitchell GF, Vasan RS, Keaney JF Jr., et al. Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation. 2004; 109(5):613-9. Epub 2004/02/11. doi: 10.1161/01.cir.0000112565.60887.1e PMID: 14769683.
34. Iwata M, Miyashita Y, Kumagai H. Seasonal variation of endothelium-dependent flow-mediated vasodilation measured in the same subjects. American journal of cardiovascular disease. 2012; 2(2):111-5. Epub 2012/06/22. PMID: 22720200; PubMed Central PMCID: PMC3371618.
35. Amir O, Alroy S, Schliamser JE, Asmir I, Shiran A, Flugelman MY, et al. Brachial artery endothelial function in residents and fellows working night shifts. The American journal of cardiology. 2004; 93 (7):947-9. Epub 2004/03/31. doi: 10.1016/j.amjcard.2003.12.032 PMID: 15050508.
36. Spieker LE, Hurlimann D, Ruschitzka F, Corti R, Enseleit F, Shaw S, et al. Mental stress induces prolonged endothelial dysfunction via endothelin-A receptors. Circulation. 2002; 105(24):2817-20. Epub 2002/06/19. doi: 10.1161/01.CIR.0000021598.15895.34 PMID: 12070106.
37. Li S, Wu Y, Yu G, Xia Q, Xu Y. Angiotensin II receptor blockers improve peripheral endothelial function: a meta-analysis of randomized controlled trials. PloS one. 2014; 9(3):e90217. Epub 2014/03/07. doi: 10.1371/journal.pone.0090217 PMID: 24595033; PubMed Central PMCID: PMC3940822.
38. Takagi H, Yamamoto H, Iwata K, Goto SN, Umemoto T. Low-density lipoprotein-independent improvement of flow-mediated dilatation with atorvastatin: a meta-analysis and meta-regression of randomized controlled trials. International journal of cardiology. 2012; 158(2):285-9. Epub 2012/05/09. doi: 10. 1016/j.ijcard.2012.04.054 PMID: 22560909.
39. Wascher TC, Schmoelzer I, Wiegratz A, Stuehlinger M, Mueller-Wieland D, Kotzka J, et al. Reduction of postchallenge hyperglycaemia prevents acute endothelial dysfunction in subjects with impaired glucose tolerance. European journal of clinical investigation. 2005; 35(9):551-7. Epub 2005/09/01. doi: 10.1111/j.1365-2362.2005.01550.x PMID: 16128861.
40. Sawada T, Shiotani H, Terashita D, Nagasawa Y, Kim SS, Koide M, et al. Comparison of effects of alpha-Glucosidase inhibitors and glinide drugs on endothelial dysfunction in diabetic patients with coronary artery disease. Circulation journal: official journal of the Japanese Circulation Society. 2014; 78 (1):248-55. Epub 2013/11/15. doi: 10.1253/circj.CJ-13-0918 PMID: 24225338.
41. Kim YG, Hahn S, Oh TJ, Kwak SH, Park KS, Cho YM. Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis. Diabetologia. 2013; 56(4):696-708. Epub 2013/01/25. doi: 10.1007/s00125-012-2827-3 PMID: 23344728.
42. Hibuse T, Maeda N, Kishida K, Kimura T, Minami T, Takeshita E, et al. A pilot three-month sitagliptin treatment increases serum adiponectin level in Japanese patients with type 2 diabetes mellitus-a randomized controlled trial START-J study. Cardiovascular diabetology. 2014; 13:96. Epub 2014/06/03. doi: 10.1186/1475-2840-13-96 PMID: 24884787; PubMed Central PMCID: PMCPmc4049487.
43. Wang X, Pu H, Ma C, Jiang T, Wei Q, Zhang C, et al. Adiponectin abates atherosclerosis by reducing oxidative stress. Medical science monitor: international medical journal of experimental and clinical research. 2014; 20:1792-800. Epub 2014/10/03. doi: 10.12659/msm.892299 PMID: 25275545; PubMed Central PMCID: PMCPmc4196893.
44. Bhagat K, Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation. 1997; 96(9):3042-7. Epub 1997/12/31. doi: 10.1161/01.CIR.96.9.3042 PMID: 9386173.
45. Hermann C, Assmus B, Urbich C, Zeiher AM, Dimmeler S. Insulin-mediated stimulation of protein kinase Akt: A potent survival signaling cascade for endothelial cells. Arteriosclerosis, thrombosis, and vascular biology. 2000; 20(2):402-9. Epub 2000/02/17. doi: 10.1161/01.ATV.20.2.402 PMID: 10669636.
46. Anuradha R, Saraswati M, Kumar KG, Rani SH. Apoptosis of beta cells in diabetes mellitus. DNA and cell biology. 2014; 33(11):743-8. Epub 2014/08/06. doi: 10.1089/dna.2014.2352 PMID: 25093391.
47. Mu J, Woods J, Zhou YP, Roy RS, Li Z, Zycband E, et al. Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes. Diabetes. 2006; 55(6):1695-704. Epub 2006/05/30. doi: 10.2337/db05-1602 PMID: 16731832.
48. Kim SJ, Nian C, Doudet DJ, McIntosh CH. Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice. Diabetes. 2008; 57 (5):1331-9. Epub 2008/02/27. doi: 10.2337/db07-1639 PMID: 18299314.
49. Shah P, Ardestani A, Dharmadhikari G, Laue S, Schumann DM, Kerr-Conte J, et al. The DPP-4 inhibitor linagliptin restores beta-cell function and survival in human isolated islets through GLP-1 stabilization. The Journal of clinical endocrinology and metabolism. 2013; 98(7):E1163-72. Epub 2013/05/02. doi: 10.1210/jc.2013-1029 PMID: 23633194.
50. Grankvist K, Marklund SL, Taljedal IB. CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. The Biochemical journal. 1981; 199(2):393-8. Epub 1981/11/01. doi: 10.1042/bj1990393 PMID: 7041886; PubMed Central PMCID: PMCPmc1163382.